Agenda Item: Enclosure E
Board of Directors
Meeting
Report
Subject:Integrated Performance Report - Exception Summary Report
Date: 7th November 2013
Author:
Lead Director:Jacqui Tuffnell, Director of Operations
Executive Summary
Performance Summary: September 2013
Monitor Compliance
Performance for September 2013 has resulted in the Trust reporting One Monitor
compliance point for Clostridium Difficile Infection .For the period April to September the
Monitor target was 13, this is based on the trajectory submitted, and the Trust is reporting 17
cases during the period. The Trust is reporting an MRSA case for the month of September
2013 but due to remaining below the deminimus this overrides any compliance point. From
October 2013 onwards MRSA is no longer part of the targets and indicators with the Monitor
Assessment Framework and will be reported within the Acute Contract section of the IPR
only.
As a consequence of the Trusts financial and governance risk ratings the Trust remains in
breach of its authorisation with automatic over-ride applying a red governance risk rating.
Acute Contract
RTT
The Trust has continued to achieve the bottom-line position for all three RTT standards in
September 2013. 90% Admitted had all reportable grouped specialties achieve the
respective target. However, both Incomplete 92% and Non-Admitted 95% had specialties
under achieve against the targets. The Trust reported zero patients on an Incomplete
Pathway waiting over 52 weeks which is the first instance since March 2013.
The Trust has reported in-month specialty breaches of the 95% non-admitted standard. Five
specialties are underachieving against the 95% target. The Trust has shared revised
specialty level recovery action plans and trajectories with the CCG which indicate the Trust
delivering the specialty level targets for the month of February 14 onwards. The trajectories
calculate a substantial level of breach patients to be treated during Quarter 3 and January
2014 to ensure a sustainable future position this places significant risk on the Trust
delivering Non-Admitted bottom-line 95% during the period October 2013 to January 2014
which would result in a Monitor breach point for the in the relevant quarter.
Due to the high volume of breaches on the T&O Incomplete admitted pathway to aid a
sustainable backlog position the performance against the 90% standard for this specialty will
fall below the target during Quarter 3, this will not impact Trust bottom-line achievement. The
CCG have been informed of the position and have agreed to the recovery plan and
timescales, this has been confirmed in email correspondence received 11th October 2013, a
formal letter will be sent. However, if the Trust fails to achieve the recovery plans and
trajectories a Failure to Deliver a Remedial Action Plan notice will be enacted along with the
financial consequences, which is 2% of clinical income.
Work has been undertaken to understand the activity volumes required in mitigating a
Monitor breach point but considerable operational and administrative changes are required.
ED
The number of ED un-planned re-attendances for a further month is above 5% for August
2013; this is again a marginal improvement from the previous month. The department to
continues to reiterate messages to patients regarding when to return, displaying messages
to patients in the waiting room, working with high volume service users and revisiting advice
leaflets to offer more specific advice.
Specific work continues to being undertaken with CCG/Primary Care around paediatric
emergency attendances and reinforcing communication regarding the use of Out of Hours
Primary Care Services before re-attending at the Childrens Emergency Department. A piece
of work is being undertaken to establish SFH performance against local and national Trust
performance for this indicator alongside a patient audit to establish themes.
Un-coded Activity
The level of un-coded admitted patient care spells at the 5th working day of the month has
slightly increased from 20.59% to 22.22% (+1.63%) against the Clinical Commissioning
Group target of 20%. Despite the marginal increase this is the first consecutive month period
which the Trust reported an un-coded volume below 25% for this financial year. The Clinical
Coding Team continues to assess processes further improve the un-coded position.
All four substantive trainee Clinical Data Capture Coders have now joined the department
and are beginning their training programme.
The Trust continues to monitor the level of un-coded activity at the first Secondary Users
Service submission point in line with PbR guidelines and is currently on trajectory to meet
the 98% coded position in April 2014.
ASI Rates
For the third consecutive month the Trust reported a Choose and Book Available Slot Issue
(ASI) rate of 8% against a target of 5%. Ophthalmology, Dermatology, Gastroenterology,
T&O, Pain Management, Paediatric Allergy, Haematology, Neurology and Vascular Surgery
were the main contributing specialties. Current performance for October 2013 indicates the
Trust being at an ASI rate of 6% which is a considerable improvement from the September
2013 position with Dermatology, Ophthalmology, Gastroenterology and Pain Management
all reducing their ASI rates.
Quality
The monthly Quality and Safety Report written by the Executive Director of Nursing and
Executive Medical Director will cover key quality domains.
HR/Workforce
A summary of the key workforce issues are grouped below, these will be expressed in more
detail within the HR paper:
Workforce Numbers & Cost – The budgeted establishment in month was 3729.32 wte an
increase of 42.98 wte and staff in post was 3482.15 wte an increase of 30.96 wte. Pay
spend in month was £13.84m (decrease of £250k), of which £11.95m was fixed pay spend
and £1.59m was variable pay spend (decrease of £300k since last month) which equates to
11.49%.
Sickness Absence – Staff absence levels have decreased in month. In August 2013 total
absence was 4.39% decreasing by 0.26% to 4.13% in September 2013. Short term
absence has increased from 2.15% to 2.42% (0.27%) and long term has decreased from
2.24% to 1.71% (0.53%). The month rate is 4.13% with the rolling 2012-13 12 month rate at
4.87% which is 0.29% higher than 2011-12 (4.58%). Absence must be effectively managed
in order to ensure levels of care are maintained and cost levels are reduced.
Agenda for Change Appraisal Completion – The current appraisal rate is 70.28% which has
increased since last month by 6.77%. Work is on-going to validate the data and managers
have now been enabled with a number of opportunities to validate the data. Since April
2013, appraisal rates have increased by 10.62% from 54.60%.
September 2013 Successes
The Trust continues to achieve the ED 4 hour target with performance in September 2013
and YTD being at 96.69%, this being despite of high volume attendances and capacity and
flow issues being experienced.
The Trust continues to receive ‘excellent’ for the NHS Friends and Family Test, with a
consistent performance above the national thresholds.
For the month of September Grade 2 Pressure Ulcers (post admission/avoidable) has seen
a further reduction, the reported volume for Quarter 2 2013/14 totals 20 which is a 50%
reduction against Quarter 1 2013/14.
Q3 13/14 Forecast Risks
Achievement of the Choose and Book appointment slot issues (ASI) continues to rely heavily
on waiting list initiatives to meet shortfalls in capacity. The target agreed with commissioners
is 5%.
Non-Admitted RTT Trust bottom-line 95% achievement is a potential risk for quarter 3 as the
Trust begins to clear breach patients within the four underachieving specialties.
Achievement of acquired C. Difficile infection against trajectory. Root cause analysis of
cases has taken place and does not suggest any issue with cross-infection. Most of these
are sporadic cases and further investigation of themes is underway.
Recommendation
For the Executive Board to receive this high level summary report for information and to
raise any queries for clarification.
Relevant Strategic Objectives (please mark in bold)
Achieve the best patient experience
Improve patient safety and provide high
quality care
Attract, develop and motivate effective
teams
Achieve financial sustainability
Build successful relationships with
external organisations and regulators
Links to the BAF and Corporate
Risk Register
Details of additional risks
associated with this paper (may
include CQC Essential Standards,
NHSLA, NHS Constitution)
Links to NHS Constitution
Financial Implications/Impact
Legal Implications/Impact
Key Quality and Performance Indicators provides
assurances on delivery of rights of patients accessing
NHS care.
The financial implications associated with any
performance indicators underachieving against the
standards are identified.
Failure to deliver key indicators results in Monitor
placing the trust in breach of its authorisation
Partnership working & Public
Engagement Implications/Impact
Committees/groups where this
item has been presented before
Monitoring and Review
Is a QIA required/been
completed? If yes provide brief
details
The Board receives monthly updates on the reporting
areas identified with the IPR.
TRUST KEY PERFORMANCE INDICATORS
Monitor compliance
September 2013
Target
Apr-13
May-13
Jun-13
Jul-13
Aug-13
Sep-13
In month
Change
Q2
2013/14
Q1
2013/14
YTD
13/14
Q4
2012/13
Q3
2012/13
2012/13
Admitted Patient Care (90% of patients
treated within 18 weeks)
>=90%
94.37%
94.83%
97.22%
94.39%
95.33%
93.57%

94.36%
95.49%
94.95%
93.34%
86.44%
88.86%
Non Admitted Patient Care (95% of
patients treated within 18 weeks)
>=95%
95.18%
95.88%
95.89%
96.07%
95.50%
95.15%

95.59%
95.65%
95.62%
95.52%
93.91%
94.71%
Incomplete Pathways (92% of patients
complete pathway within 18 weeks)
>=92%
95.52%
95.71%
95.11%
95.06%
94.59%
93.83%

SFHFT (% <4 hour wait)
>=95%
93.50%
98.20%
98.47%
96.37%
97.81%
95.77%

96.66%
Kings Mill (% <4 hour wait)
>=95%
91.20%
97.74%
98.11%
95.26%
97.04%
94.13%

Newark (% <4 hour wait)
>=95%
98.42%
98.67%
98.80%
97.99%
99.06%
99.29%
2 week wait: All Cancers
>=93%
93.59%
94.25%
94.55%
94.47%
92.67%
2 week wait: Breast Symptomatic
>=93%
97.67%
97.67%
97.44%
95.35%
31 day wait: from diagnosis to first
treatment
>=96%
100.00%
100.00%
99.15%
31 day wait: for subsequent treatment surgery
>=94%
100.00%
100.00%
31 day wait: for subsequent treatment drugs
>=98%
100.00%
62 day wait: urgent referral to
treatment
>=85%
62 day wait: for first treatment screening
MONITOR COMPLIANCE FRAMEWORK
Ref.
Referral to Treatment:
A&E Clinical Quality:
Total Time in A&E Dept
Cancer
Data Completeness:
Infection Prevention Control:
95.24%
93.51%
95.24%
-
March 13
Snapshot
position
December 12
Snapshot
position
March 13
Snapshot
position
96.73%
96.69%
93.43%
92.74%
94.34%
95.48%
95.67%
95.58%
91.13%
90.66%
92.85%

98.75%
98.63%
98.69%
98.78%
99.13%
99.20%
(94.38%)

(93.86%)
94.13%
(93.98%)
95.48%
96.23%
95.83%
93.33%
(96.43%)

(95.05%)
97.60%
(96.46%)
95.08%
94.87%
95.54%
100.00%
99.11%
(98.78%)

(99.37%)
99.70%
(99.54%)
99.30%
99.39%
99.43%
88.89%
100.00%
100.00%
(100.00%)

(100.00%)
96.67%
(97.87%)
100.00%
100.00%
98.65%
100.00%
100.00%
100.00%
100.00%
(100.00%)

(100.00%)
100.00% (100.00%) 100.00%
100.00%
100.00%
89.66%
88.06%
95.83%
90.00%
86.51%
(89.71%)

(88.83%)
91.37%
(90.07%)
89.29%
89.56%
90.78%
>=90%
100.00%
100.00%
100.00%
100.00%
100.00%
(100.00%)

(100.00%)
100.00% (100.00%)
97.67%
90.57%
94.95%
Community Referral to Treatment
information
>=50%
78.47%
82.42%
84.31%
86.41%
86.10%
85.24%

85.92%
81.81%
83.84%
78.46%
72.94%
74.35%
Community Referral information
>=50%
54.00%
54.12%
54.34%
53.82%
54.20%
54.77%

54.26%
57.42%
54.21%
54.28%
54.03%
54.37%
Community Treatment activity - and
care contact
>=50%
76.38%
76.58%
77.08%
77.11%
76.85%
77.36%

77.11%
76.69%
76.90%
67.82%
68.54%
68.77%
MRSA Bacteraemia (No. of cases
attributed to Trust)
0
0
1
0
1
0
1

2/0
1/0
3/0
0
0
0
Clostridium Difficile Infections (No. of
cases attributed to Trust)
2
2
4
2
2
4
3

9/7
8/6
17/25
12/9
8/9
29/36
1.0
1.0
2.0
3.0
RED
RED
RED
RED
Access to Healthcare for people with learning disabilities
CQC Compliance
compliance points relative to site visits
Compliance
0
Compliant
93.83%
Sept
13 Snapshot
position
95.11%
June
13 Snapshot
position


Monitor Compliance Points
Governance Risk Rating (GRR)
N/A
N/A
TRUST KEY PERFORMANCE INDICATORS
Acute Contract Performance
September 2013
Target
Apr-13
May-13
Jun-13
Jul-13
Aug-13
Sep-13
In month
change
Q2
2013/14
Q1
2013/14
YTD
2013/14
Q4
2012/13
Q3
2012/13
Full Year
2012/13
SFHFT (% <4 hour wait) Total Time in A&E Dept
>=95%
93.50%
98.20%
98.47%
96.37%
97.81%
95.77%

96.66%
96.73%
96.69%
93.43%
92.74%
94.34%
Unplanned re-attendance rate within 7 days of
original attendance
<=5%
6.24%
4.93%
5.44%
5.51%
5.46%
5.36%

5.45%
5.53%
5.49%
5.02%
5.94%
5.70%
Left without being seen rate
<=5%
1.70%
1.63%
1.63%
2.10%
1.58%
1.46%

1.73%
1.66%
1.70%
1.73%
2.11%
2.08%
Time to Initial Assessment for patients arriving
by emergency ambulance (95th percentile Mins)
<=15
35
27
26
29
26
27

28
29
28
33
42
39
Time to Initial Assessment for patients arriving
by emergency ambulance (Median Minutes)
<=16
4
4
4
4
4
4

4
4
4
5
7
6
Time to Treatment (Median minutes wait from
arrival to treatment)
<=60
54
51
50
57
40
42

46
52
49
55
57
56
CONTRACTUAL PERFORMANCE METRICS
Ref
A&E Clinical Quality:
Ambulance Turnaround
Times
Average Clinical Handover Time (%)
>=65%
55.84%
65.34%
63.80%
59.72%
61.89%
64.79%

62.16%
61.52%
61.85%
54.69%
51.17%
55.64%
Delayed Transfer of Care
Trust Total % (at snapshot position)
3.50%
3.54%
4.78%
5.38%
4.65%
4.94%
4.37%

4.65%
4.54%
4.59%
3.63%
6.75%
5.97%
% Of elective admissions
<=0.8%
0.41%
0.36%
0.47%
0.39%
0.29%
0.64%

0.45%
0.41%
0.44%
0.82%
0.98%
0.71%
% Breached 28 day guarantee
<=5%
0.00%
0.00%
0.00%
0.00%
11.11%
0.00%

2.22%
0.00%
1.14%
0.00%
0.95%
0.75%
Diagnostic waiting times
<6weeks
%
>=99%
99.49%
99.64%
99.49%
99.84%
99.82%
99.84%

-
-
-
-
-
-
Choose & Book:
Ratio: Slot issues per booking
<0.05
0.05
0.09
0.09
0.08
0.08
0.08

-
-
0.08
Cancelled Operations:
SUS data:
Referral to Treatment:
% uncoded within 5 days of month end
<20%
36.51%
26.53%
39.66%
27.92%
20.59%
22.22%

-
-
-
-
-
Admitted Patient Care (90% of patients
treated within 18 weeks)
>=90%
94.37%
94.83%
97.22%
94.39%
95.33%
93.57%

94.36%
95.49%
94.95%
93.34%
86.44%
88.86%
Non Admitted Patient Care (95% of patients
treated within 18 weeks)
>=95%
95.18%
95.88%
95.89%
96.07%
95.50%
95.15%

95.59%
95.65%
95.62%
95.52%
93.91%
94.71%
Incomplete Pathways (92% of patients
complete pathway within 18 weeks)
>=92%
95.52%
95.71%
95.11%
95.05%
94.59%
93.83%

-
-
-
-
-
-
18week RTT for direct access audiology
completed pathways (treated)
>=95%
99.68%
99.63%
99.64%
99.47%
99.63%
99.62%

99.56%
99.65%
99.60%
99.35%
99.75%
99.69%
0
2
1
1
2
1
0

-
-
-
-
-
-
2 week wait: All Cancers
>=93%
93.59%
94.25%
94.55%
94.47%
92.67%
(94.38%)

(93.86%)
94.13%
(93.98%)
95.48%
96.23%
95.83%
2 week wait: Breast Symptomatic
>=93%
97.67%
97.67%
97.44%
95.35%
93.33%
(96.43%)

(95.05%)
97.60%
(96.46%)
95.08%
94.87%
95.54%
31 day wait: from diagnosis to first treatment
>=96%
100.00%
100.00%
99.15%
100.00%
99.11%
(98.78%)

(99.37%)
99.70%
(99.54%)
99.30%
99.39%
99.43%
31 day wait: for subsequent treatment surgery
>=94%
100.00%
100.00%
88.89%
100.00%
100.00%
(100.00%)

(100.00%)
96.67%
(97.87%)
100.00%
100.00%
98.65%
31 day wait: for subsequent treatment - drugs
>=98%
100.00%
100.00%
100.00%
100.00%
100.00%
(100.00%)

(100.00%)
100.00%
(100.00%)
100.00%
100.00%
100.00%
62 day wait: urgent referral to treatment
>=85%
89.66%
88.06%
95.83%
90.00%
86.51%
(89.71%)

(88.83%)
91.37%
(90.07%)
89.29%
89.56%
90.78%
62 day wait: for first treatment - screening
>=90%
100.00%
100.00%
100.00%
100.00%
100.00%
(100.00%)

(100.00%)
100.00%
(100.00%)
97.67%
90.57%
94.95%
62 day wait: consultant upgrade
>=91%
100.00%
100.00%
100.00%
100.00%
100.00%
(100.00%)

(100.00%)
100.00%
(100.00%)
86.36%
91.67%
93.64%
MRSA Bacteraemia (No. of cases attributed to
Trust)
0
0
1
0
1
0
1

2/0
1/0
3/0
0
0
0
Clostridium Difficile Infections (No. of cases
attributed to Trust)
2
2
4
2
2
4
3

9/7
8/6
17/25
12/9
8/9
29/36
Patients on an Incomplete Pathway waiting 52
weeks & Over
Cancer
Infection Prevention
Control:
denotes when the target is a contractual and Monitor performance target that is
replicated in the Monitor compliance dashboard
TRUST KEY PERFORMANCE INDICATORS
18 Weeks
September 2013
REFERRAL TO TREATMENT (RTT) - 18 WEEKS
Monitor Compliance
For the month of September 2013 all three RTT targets achieved the required standard for Monitor compliance, however there are in-month specialty breaches within Incomplete Pathway
(T&O) and Non-Admitted.
Quality
For the month of September 2013 zero patients on an Incomplete Pathway were waiting beyond 52 weeks. As part of the week 18 Week Delivery Group the RTT Action Plan and Risks and
Issues Log are reviewed in detail with key focus areas being identified and monitored. The Trust has produced and shared revised specialty action plans for those specialties failing the nonadmitted target along with trajectories detailing achievement timeline of February 2014.
The Trust has recently reviewed the RTT delivery plan with the CCG and IST to review progress against agreed action and have agreed the following key actions:
• RTT Training to be undertaken across clinical specialties
• Actively monitoring diagnostic pathways on a weekly basis and tacking remedial actions
• Outsourcing work ( if clinically appropriate) within T/O
• Clinic outcome forms work continues – some specialties had been done. The Trust was targeting the failing specialties first. There was good clinical engagement.
• To reduce waiting times within a patient pathway for an Inter Consultant Referral clinical teams have agreed for an appointment to be booked immediately based on the referring
consultants clinical grading.
• SOPs are being developed for the administrative teams to ensure processes are clear, followed and the relevant administrative event is captured to aid capturing where a patient is on their
pathway. The first phase is covering Outpatient Dictation including letter outcomes, Inter Consultant Referrals, Inter Provider Transfers and Correspondence Actions.
Operational
Management to achieve the 92% target continues to impact upon delivery of the 95% non-admitted target for particular
specialties as evidenced in the adjacent table. The backlog to be cleared indicates a significant impact to the Trust bottom-line
achievement of the Non-Admitted 95% standard which will result in one Monitor breach point for Quarter 3 and potentially
Quarter 4. RTT meetings continue to monitor progress and drive delivery including; weekly performance meetings with the
CCGs, weekly waiting list management group, patient waiting times meeting and departmental communication cells. The
weekly Patient Waiting Times meeting attended by operational teams representing all points across a patients pathway track
and progress patients on their RTT pathway, currently the focus is at an individual patient for those waiting 24 weeks and over.
This will continue to reduce over the coming weeks. The RTT validation team review every incomplete patient pathway for
patients waiting beyond 18 weeks with a view to prevent extensive waits and take any potential issues to the weekly patient
waiting times meeting for resolution. The team has also introduced reviewing patients between 12 and 17 weeks on
specialties which have potentially multiple diagnostics to ensure patients are being progressed. The CCG continue to monitor
with the Trust patients waiting 42 weeks and beyond to establish the actions being taken on individual patient pathways.
Referral to Treatment September 2013 Summary
RTT Specialty
General Surgery
Urology
T&O
ENT
Ophthalmology
MaxFax
Plastic Surgery
Cardiothoracic
Gastroenterology
Cardiology
Dermatology
Respiratory Medicine
Neurology
Rheumatology
Geriatrics
Gynaecology
Others
Total
Incomplete
92.48%
93.35%
88.68%
94.21%
97.38%
93.14%
97.14%
100%
92.44%
92.38%
97.16%
96.44%
96.86%
98.13%
99.21%
96.31%
93.15%
93.83%
RTT Standard
Admitted
Non-Admitted
90.94%
94.14%
91.54%
92.44%
90.67%
87.76%
95.40%
97.93%
95.76%
98.27%
94.92%
98.18%
100%
96.15%
100%
90.00%
97.84%
100%
95.71%
90.38%
93.57%
86.81%
96.19%
97.98%
90.45%
93.34%
98.72%
98.63%
96.86%
95.54%
95.15%
Acute Contract
The Trust has failed to deliver the national quality standard for non-admitted patients at a speciality level and will incur penalties. The total RTT penality reported within the finance position
as at September 2013 is £84,976.
TRUST KEY PERFORMANCE INDICATORS
Quality & Safety
September 2013
Target
Ref.
Apr-13
May-13
Jun-13
Jul-13
Aug-13
Sep-13
In month
change
Q2
2013/14
Q1
2013/14
Q4
2012/13
Q3
2012/13
2012/13
YTD
2013/14
2.5
1
1
4
0
0
3

3/2.5
6/2.5
3
6
13
9/7.5
2
4
2
7
1
2
3
5

10/12
10/12
13
19
32
0
0
12
1
2
0
0
0
1

1/12
3/12
1
0
2
Other Urinary Catheter Associated Bacteraemia (No. of
hospital acquired cases)
0
0
1
1
1
0
0
0
0

0/1
2/1
1
0
3
Surgical Site Infections (Total Knee Replacement
surgery)
0
0
1
0
0
0
0
0
0

0/1
0/1
0
0
0
Surgical Site Infections (Total Hip Replacement surgery)
0
0
1
1
0
0
0
0
0

0/1
1/1
0
0
2
Medication, storage and custody
>90%
>85%
<85%
94%
79%
96%
93%
97%
-
95%
90%
94%
93%
94%
95%
Infection control/privacy & dignity
>90%
>85%
<85%
97%
93%
94%
-
-
-
-
95%
98%
95%
96%
-
95%
97%
-
96%
99%
99%
-
99%
89%
91%
-
90%
88%
90%
88%
87%
90%
86%
88%
-
87%
90%
86%
89%
88%
87%
93%
93%
-
93%
90%
82%
87%
86%
93%
81%
85%
-
83%
94%
94%
96%
94%
83%
QUALITY & SAFETY METRICS
Infection Prevention
Control:
G
A
R
MSSA Bacteraemia (No. of hospital acquired cases)
0
0
E Coli bacteraemia (No. of Hospital acquired cases)
0
E. Coli Urinary Catheter Associated Bacteraemia (No. of
hospital acquired cases)
Infection control
Data not available prior to use of
FOCUS IT
Privacy & dignity
Data not available prior to use of
FOCUS IT
>90%
>85%
<85%
89%
85%
90%
Pain Management
>90%
>85%
<85%
89%
86%
93%
Nutritional Assessment
>90%
>85%
<85%
97%
82%
91%
Tissue Viability
>90%
>85%
<85%
92%
95%
97%
Falls Assessment
>90%
>85%
<85%
97%
92%
91%
92%
95%
-
94%
93%
94%
96%
96%
94%
Continence Assessment
>90%
>85%
<85%
97%
93%
92%
88%
84%
-
86%
94%
93%
94%
93%
86%
0
-
>0
0
0
0
1
0
0

1
0
0
0
0
1
<21
21-27
>28
14
14
6
9
2
5

16
34
32
31
98
50
Catastrophic-Death *(Live reporting system-updates can
affect numbers on daily basis)
0%
-
0%
0 (0%)
0 (0%)
0 (0%)
1 (<1%)
0 (0%)
2 (<1%)

3
0
2
3
6
3
Severe harm *(Live reporting system-updates can affect
numbers on daily basis)
Never Event (number of reported events)
Serious Incidents (reported externally to CCG)
Medication related
incidents
Data not available prior to use of FOCUS IT
Patient observations/ACAT
Nursing Metrics:
Patient Safety Incidents
Data
collection
method
and source
has been
updated to
FOCUS IT.
Pilot in July
2013, new
data
format will
be
provided
for August
2013
period
0%
-
0%
0 (0%)
0 (0%)
1 (<1%)
0 (0%)
1 (<1%)
4 (<1%)

1
1
0
1
3
2
Moderate harm *(Live reporting system-updates can
affect numbers on daily basis)
<=5%
-
>5%
20 (4%)
21 (4%)
19 (4%)
22 (4%)
15(3%)
73 (10%)

110
60
20
52
154
170
Low harm *(Live reporting system-updates can affect
numbers on daily basis)
<=23%
-
>23%
62 (12%)
80 (14%)
86 (17%)
82 (14%)
82 (15%)
159 (21.8%)

164
228
90
240
787
392
No harm *(Live reporting system-updates can affect
numbers on daily basis)
>=72%
-
<72%
437 (84%)
458 (82%)
398 (79%)
488 (82%)
426(81%) 492 (67.4%)

1406
1293
473
1325
4152
2699
0.06
Number of medication errors per 1000 occupied bed
days resulting in serious harm
-
-
-
0.00
0.00
0.00
0.00
0.05
0.29

0.11
0.00
New methodology agreed for
2013/14
Falls rate per 1000 occupied bed days
-
-
-
7.90
7.77
6.64
7.90
7.99
7.30

7.76
7.46
New methodology agreed for
2013/14
7.58
Falls rate per 1000 occupied bed days resulting in harm
-
-
-
1.17
1.29
1.44
1.85
2.38
1.54

1.80
1.30
New methodology agreed for
2013/14
1.44
Grade 2 *(Live reporting system-updates can affect
numbers on daily basis)
<5
>=5<=10
> 10
14
13
16
8
7
5

20
43
54
30
135
58
Grade 3 *(Live reporting system-updates can affect
numbers on daily basis)
<2
>=2<=4
>4
5
4
2
0
1
0

1
11
9
6
23
12
Grade 4 *(Live reporting system-updates can affect
numbers on daily basis)
0
-
>=1
0
0
0
0
0
0

0
0
0
1
2
0
1.28
1.30
>1:30
01:30
N/A
N/A
1.28
01:34
01:33
01:32.1
1.28
Slips, trips and falls
Pressure Ulcer (post
admission/avoidable
*from April 2012)
Midwife to birth ratio
Cardiac Arrest Calls (outside of ICCU)- 1-5 per 1000 admission)
Number of Calls to
Outreach Team
<3.5 per >3.5 per
1000
1000
1.7
2.5
2.2
1.3
1.4
2.0

1.6
2.2
2.1
3.1
3.0
1.9
-
-
-
131
108
102
111
116
111

338
341
362
359
1309
679
Acute
-
-
-
101
71
70
73
74
79

226
242
258
233
844
468
-
Information Governance (Scores for IG Toolkit)
Eliminating Same Sex Accommodation Breaches (No of breaches)
-
-
30
37
32
38
42
32

112
99
104
126
465
211
>=70%
scored at
Level 2
-
<70%
scored at
Level 2
72%
72%
72%
72%
72%
72%

72%
72%
72%
49%
64%
72%
0
-
>=1
0
0
0
0
0
0

0
0
0
0
0
0
59
57
53
60
72
65

197
169
219
174
683
366
0.15%
0.14%
0.13%
0.13%
0.19%
0.16%

0.16%
0.14%
No of complaints received in month
<=0.10%
0.11% >=0.20%
0.19%
% against activity complaints received in month
New methodology agreed for
2013/14
0.15%
>=96%
81-95%
<=80%
94%
33%
79%
100%
100%
100%

100%
69%
77%
84%
89%
No of contacts
-
-
-
660
613
569
649
667
659

1975
1842
1933
2141
8531
3817
Compliments
-
-
-
140
98
79
58
80
93

231
317
240
246
915
548
Comments
-
-
-
249
228
211
247
238
233

718
688
847
788
3593
1406
263
278
259
347
334
319

1000
800
779
1052
3822
1800
0.65%
0.66%
0.66%
0.77%
0.88%
0.77%

0.80%
0.66%
New methodology agreed for
2013/14
0.73%
17
15
25
12
15
14

41
57
0.04%
0.04%
0.06%
0.03%
0.04%
0.03%

0.03%
0.05%
(Acknowledgement)
PALs
>5 per
1000
Total
Follow Up (seen by critical care on discharge from ICCU
Improving Patient
Experience
1.28
Concerns - volume received
<=0.10%
0.11% >=0.20%
0.19%
Concerns - % against activity
First Line Complaints - volume received
<=0.10%
0.11% >=0.20%
0.19%
Complaints - % against activity
67
55
201
New methodology agreed for
2013/14
98
0.04%
NHS Friends and Family Test (5 start rating scoring)
>=4
>=3.5
<3.5
4.6
4.6
4.6
4.6
4.8
4.5

4.6
4.6
2012/13 data not
collected in Five Star
rating method
NHS Friends and Family Test (proportional score) (DH
deem above 50 as excellent)
50
45
40
61
63
61
60
61
60

60
61
2012/13 data not
collected in Five Star
rating method
N/A
N/A
Heart Attacks Secondary Prevention
>90%
90%
<90%
N/A
98.42%
99.60%
N/A
N/A
HSMR
<=100
-
>100
N/A
96.8
118.5
N/A
N/A
Net Promoter
Denotes not applicable at time of report
Not available at time of report publication
Monthly Trend



Improved Performance
In line with previous period
Deterioration in Performance




Achieving threshold improving performance
Achieving threshold deteriorating performance
Failing threshold improving performance
Failing threshold deteriorating performance
96.32%
N/A
N/A
TRUST KEY PERFORMANCE INDICATORS
HR/Workforce
September 2013
Code
HR WORKFORCE METRICS
Target effective from 1st April 13 (establishment target based on
end of year target requirement)
G
Establishment
Staff in Post
A
< or = 3666.58
Apr-13
May-13
Jun-13
Jul-13
Aug-13
Sep-13
In month
change
Q2 2013/14
Q1 2013/14
Q4 2012/13
Q3 2012/13
Q2 2012/13
YTD 2013/14
>3666.58
3653.84
3668.10
3678.00
3687.56
3686.34
3729.32
-1.22
3701.07
3666.65
3484.59
3489.59
3490.96
3683.86
R
-
-
-
3389.19
3412.90
3433.86
3437.74
3451.19
3482.15
13.45
3457.03
3411.98
3346.16
3352.58
3337.64
3434.51
< or = 7.50%
> 7.50% & < 10.00%
>10.00%
-264.65
-255.20
-244.14
-249.82
-235.15
-247.17
14.67
-247.17
-254.66
-138.44
-137.01
-153.32
-249.36
<9.45%
>9.45% & <10.40%
>10.40%
0.95%
1.46%
2.33%
3.09%
3.88%
4.99%
0.79%
4.99%
2.33%
9.73%
7.35%
4.96%
2.78%
<1.52%
>1.52% & <1.68%
>1.68%
3.02%
2.48%
2.66%
2.48%
2.15%
2.42%
-0.33%
2.35%
2.72%
2.73%
2.63%
2.23%
2.54%
<1.64%
>1.64% & <1.82%
>1.82%
1.81%
2.15%
2.05%
2.21%
2.24%
1.71%
0.03%
2.05%
2.00%
2.44%
2.56%
2.00%
2.03%
<3.51%
>3.51% & <3.85%
>3.85%
4.83%
4.63%
4.71%
4.69%
4.39%
4.13%
-0.30%
4.40%
4.72%
5.17%
5.19%
4.23%
4.56%
-
-
-
£264,339
£220,772
£175,504
£214,666
£148,755
£205,686
-£65,911
£569,107
£660,615
£658,287
£654,933
£548,542
£1,229,722
-
-
-
£161,228
£189,457
£209,172
£189,805
£160,488
£159,064
-£29,317
£509,357
£559,857
£613,486
£660,186
£476,994
£1,069,214
Workforce Numbers
Vacancies
(Diff between Bud. Est. & SIP)
Turnover Rate (%)
Sickness Absence (%) - Short Term
Sickness Absence (%) - Long Term
Sickness Absence (%) - Total
Absence Cost (£) - Short Term*
Absence Cost (£) - Long Term*
Attendance and Wellbeing - * This is the cost
of salary paid to those who were absent due
Absence Cost (£) - Total*
to sickness.
-
-
-
£425,567
£410,229
£384,676
£404,471
£309,243
£364,750
-£95,228
£1,078,464
£1,220,472
£1,271,773
£1,315,119
£1,025,536
£2,298,936
Absence 12 month rolling rate (%) - Short
Term
<1.52%
>1.52% & <1.68%
>1.68%
2.51%
2.56%
2.58%
2.59%
2.61%
2.61%
0.02%
2.60%
2.55%
2.43%
2.33%
2.20%
2.58%
Absence 12 month rolling rate (%) - Long
Term
<1.64%
>1.64% & <1.82%
>1.82%
2.27%
2.24%
2.25%
2.27%
2.27%
2.26%
0.00%
2.27%
2.25%
2.28%
2.29%
2.38%
2.26%
<3.51%
>3.51% & <3.85%
>3.85%
4.78%
4.80%
4.83%
4.86%
4.88%
4.87%
0.02%
4.87%
4.80%
4.70%
4.62%
4.58%
4.84%
-
-
-
88.24
89.85
87.51
85.86
86.02
82.41
0.16
84.76
88.53
87.33
88.50
88.82
86.65
-
-
-
£61,866
£62,106
£62,232
£62,713
£61,932
£61,971
-£781
£62,205
£62,068
£62,514
£62,187
£61,917
£62,137
Absence 12 month rolling rate (%) - Total
Maternity (WTE on maternity in month)
Annual Clinical Income per WTE (£)
Income and Staff Costs
Staff Performance
Annual Average Salary per WTE (£)
AFC Rolling 12 month Appraisal
completion rate
Mandatory Training Completion
-
-
-
£46,483
£46,263
£45,907
£46,099
£46,190
£45,815
£91
£46,035
£46,218
£45,752
£45,221
£45,672
£46,126
>79%
>79% & <71%
<71%
54.34%
54.97%
60.82%
65.07%
65.15%
70.28%
0.08%
70.28%
60.82%
46.81%
48.00%
47.00%
70.28%
>98%
>88% & <98%
<88%
75.00%
75.00%
75.00%
76.00%
76.00%
75.00%
0.00%
75.00%
75.00%
74.00%
71.00%
73.00%
75.00%
TRUST KEY PERFORMANCE INDICATORS
Workforce/Human Resources
September 2013
Workforce Summary
Key Issues:a. Workforce Numbers & Cost – The budgeted establishment in month was 3729.32 wte an increase of 42.98 wte and staff in post was 3482.15 wte an increase of 30.96 wte. This is to support an initiative set
out in the annual plan to translate variable pay to substantive posts to reduce the reliance on alternative costly staffing options. Pay spend in month was £13.84m (decrease of £250k), of which £11.95m was
fixed pay spend and £1.59m was variable pay spend (decrease of £300k since last month) which equates to 11.49%.
b. Sickness Absence – Staff absence levels have decreased in month. In August 2013 total absence was 4.39% decreasing by 0.26% to 4.13% in September 2013. Short term absence has increased from 2.15%
to 2.42% (0.27%) and long term has decreased from 2.24% to 1.71% (0.53%). The month rate is 4.13% with the rolling 2012-13 12 month rate at 4.87% which is 0.29% higher than 2011-12 (4.58%). Absence
must be effectively managed in order to ensure levels of care are maintained and cost levels are reduced.
c. Agenda for Change Appraisal Completion – The current appraisal rate is 70.28% which has increased since last month by 6.77%. Work is ongoing to validate the data and managers have now been enabled
with a number of opportunities to validate the data. Since April 2013, appraisal rates have increased by 10.62% from 54.60%.
Workforce Numbers
a) Budgeted Establishment - In comparison to last month, budgeted establishment has increased by 42.98 wte to 3729.32 wte. Budgeted establishment (3729.32 wte) is consistent with the annual plan
projection of 3729.54 wte, which is the first occurrence for financial year 2013-14.
b) Staff in post - has increased by 30.96 wte to 3482.15 wte in September 13 from 3686.34 wte in August 13.
c) The number of vacant posts is currently 247.17 wte which is an increase of 12.02 wte since August 13. The Trust vacancy rate is 6.63%, the majority of vacancies continue to be in registered Nursing
(112.25 wte/9.13% vacancy rate).
d) Comparison with 12/13 - The current budgeted establishment is 3729.32 wte which is 237.92 wte above than the budgeted establishment position of 3491.40 wte at September 12. When comparing
current staff in post 3482.15 wte is 151.05 wte above September 12, 3331.10 wte.
e) Against Annual Plan - In terms of annual plan, we are in line with projections of 3729.54 wte and are under plan by 0.22 wte.
f) Turnover - current FYTD turnover is 4.99% which is consistent with the rate for the same period 12/13 of 4.96%. This does not include junior doctors leaving for rotation.
Attendance & Wellbeing
a) In Month - Trust absence levels have decreased in month by 0.26% to 4.13%. When comparing against September 12, the absence rate was 4.24%, with absence for September 13 0.11% below the same
period last year.
b) Rolling 12 Months Absence - The rolling 12 month period absence is currently 4.87% which is 1.37% above the target of 3.50%. This is 0.29% above the same period for October 11 to September 12 of
4.58%
c) Absence Cost - The cost of salary paid to absent staff for September was £365k, for the 12 month rolling year this equates to £4.86m. This is the direct cost of paying staff whilst they are on sick leave and
does not account for additional hours/overtime/bank/agency used.
d) Occupational Health activity - During September 13 there have been a total of 81 referrals to Occupational Health to support staff at work/returning to work, this is a decrease since last month of 8.64%.
e) Sickness Actions - Monthly confirm and challenge sessions continue with managers of high absence areas to present challenge and also receive feedback on issues preventing the effective management of
absence. All managers continue to provided on a monthly basis absence dashboards to assist them in the management of sickness absence within their area of responsibility.
f) The top three absence reasons for all staff : 1) Anxiety/ stress/ depression/ other psychiatric illnesses (19.03%), 2) Gastrointestinal problems (10.25%) 3) Other Musculoskeletal problems (9.87%).
Workforce Productivity & Staff Costs
a) Clinical Income - Current financial year to date clinical income is £62k per WTE which remains static with August 13.
b) Average Salary - Average salary per WTE of £46k in August 13 which remains static since January 13. This is expected to increase in October due to the number of increments which are due in month (260
staff).
c) Pay Spend - In month the total pay spend was £13.84m, of which £11.95m was fixed pay spend. Total pay spend is below total pay spend plan of £13.89m by £0.05m.
d) Variable Pay - spend was £1.59m for September 13 (11.49% of total pay spend), which is a decrease against last month, however remains above the variable pay spend plan of £0.75m.
Staff Training & Development
a) Mandatory training - the current rate is 75% which is a 1% decrease from the Aug 13 position of 76%.
b) The Trust will be undertaking its annual Deanery accreditation inspection of Post Graduate Medical Education on 23rd October 2013.
c) From the 1st April 2013 to the end of August 2013, a total of 414 mandatory training places have been wasted due to staff not turning up on the day. This is the equivalent of 4 mandatory training courses
being lost or the equivalent of £12,200 in staffing and room costs being wasted. This is receiving focused attention via Team Brief.
d) A new persistent offenders report has been developed which in July 2013 identified that there were over 400 staff who were at least 3 months out of date with their mandatory training and over 242 of
these staff were at least 6 months out of date.
Recruitment & Selection
a) New Consultants:
- No Consultants starters to report.
b) Consultants Leaving:
- No Consultants leaving to report
Workforce Change
a) The CIP target of £13.3m requires workforce savings of £9.6m. There are approximately 90 schemes in progress in terms of workforce related CIP schemes. There is still a requirement for more CIP
schemes relating to workforce to be scoped and these need to be commenced through the workforce change cycle to ensure they are implemented to meet the saving requirement; variances of those plans
scoped against the annual plan will be analysed to understand where more schemes are required to close this gap. Activity needs to commence to commence planning for 14/15 CIP schemes.
Health & Safety
a) There has been no formal contact between the Trust and the HSE this month.
Fire & Security
a) Following a burglary that took place on 18th September at Newark hospital, in which two people attempted to steal the till from the cafeteria, justice has prevailed and one the
individuals involved received a 6 month custodial sentence. The other is being referred for social reports prior to sentence.
Serious Disciplinary & Tribunal Cases
a) Activity Summary - As at the end of September 2013 there are 17 formal cases in process with HR under Trust Policies, of which 6 have been disciplinary related, 2 case relates to capability issues, 4
harassment/bullying cases, 3 referrals, 1 grievance and 1 whistleblowing. There are currently two employment tribunals underway.
Workforce Performance Indicators
Key Issues - September 2013
–
–
–
–
–
Summary – Staff Numbers and Pay Spend
Progress - Pay spend and staff numbers remain within plan.
Risk – % of Variable pay against total pay spend has reduced since last month, however still
remains high. In October 2013 a high number of staff (260) are due increments, of which 213
have had an appraisal within the last 12 months and will move through to the next incremental
point impacting on the pay expenditure from October 2013 and will be reported in next months
information.
Action Required - Recruit to posts substantively where possible to avoid use of variable pay.
Currently under spending on fixed plan.
–
–
See Dashboard 1 – Sickness Absence Summary
Summary – Sickness Absence
Progress Absence total rate (4.13%), decreased in month by 0.26%; short term absence
(2.42%) has increased by 0.27% since last month and long term (1.71%) has decreased by 0.53%.
Absence has decreased month on month since July 2013. Areas of concern have been identified
and HR are working with managers to support in appropriate absence management of those
concerned.
Risk - Absence continues at the rate of last year this impacts on clinical care and cost, despite an
increase in support to managers and performance management meetings. If last three year trend
is repeated, it is anticipated that there will be an increase in absence in October 13 (from 2010
there has been an average increase in Sep to Oct of 0.58%).
–
–
–
–
–
–
Summary – Appraisal Completion
Progress - Appraisal rate has increased from 63.51% in August 13 to 70.28% in September 13 by
6.77%
Risk - Appraisal rate is still below the target of 79% by 9%, however if the number of appraisals
continues to run at the same completion rate, it is expected that we will have achieved this by the
end of the calendar year (based on an average monthly increase of 3.14% since April 13).
Action Required - Managers need to ensure they have appraisals completed & reported and
future appraisals scheduled. HR to continue to assist managers with the return of information to
enable a fuller reporting picture.
Dashboard 1: Sickness Absence Summary - September 13
6.00%
5.50%
Progress since
last month/ RAG
Rolling 12
Measure
In month
FYTD
month
Short Term
2.42%
2.66%
2.61%
Long Term
1.71%
2.06%
2.26%
Total
4.13%
4.71%
4.87%
Direct cost of paying staff whilst absent from work due to sickness
Short Term
£205,686
£1,264,688 £2,577,908
Long Term
£159,064
£1,034,018 £2,307,690
Total
£364,750
£2,298,706 £4,885,598
Sep-13
TOTAL
Top 3 Staff Groups In Month
Progress
5.95%
Unregistered
Nursing
£53,142
Scientific &
Professional
5.43%
£40,227
Technical & Other
£23,584
In Month
Progress
4.98%
DRD
£113,033
4.13%
3.90%
PCS
£111,671
3.81%
ECM
£101,676
£364,750
3.64%
Corporate
£38,371
SHORT-TERM
4.50%
4.00%
3.50%
3.00%
2.50%
2.00%
1.50%
1.00%
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
12/13 ST Absence
13/14 ST Absence
12/13 LT A bsence
13/14 LT A bsence
12/13 Tota l A bse nce
13/14 Tota l A bse nce
Mar
Last month the highest absence staff groups w ere
1) Nursing Unregistered 2) Ancillary 3) Technical & Other
The rank of divisions last month, the areas w ith highest to low est absence w ere:
1) DRD 4.81% 2) ECM 4.64% 3) PCS 4.38% and 4) Corporate 2.95%.
5.24%
Divisions
5.00%
Top 3 SMT's
In Month
DRD - New ark
7.63%
DRD - Support Services
5.12%
DRD - Pathology Services
5.12%
PCS - Trauma & Orthopaedics
PCS - Support Services
PCS - Maternity & Gynaecology
4.74%
4.32%
4.05%
ECM - Community Services
ECM - Gastro Endocrine
ECM - Support Services
4.92%
4.64%
4.01%
Corp - Inf ormation Services
Corp - Nursing Services
7.19%
6.40%
Corp - Finance
5.20%
Progress
No change
Top 3 Staff Groups In Month
Progress
4.22%
Ancillary
£3,453
3.92%
Technical & Other
£17,937
Unregistered
Nursing
Divisions
3.45%
£30,797
In Month
Progress
2.83%
2.42%
DRD
£62,567
80538
2.52%
PCS
£70,832
2.19%
£205,686
ECM
£54,137
1.78%
Corporate
£18,148
LONG-TERM
Top 3 SMT's
In Month
DRD - New ark
3.64%
DRD - Pathology Services
3.37%
DRD - Support Services
3.27%
PCS - Support Services
PCS - General Surgery
PCS - Paediatrics & Neonatal
3.18%
2.79%
2.46%
ECM - Community Services
ECM - Cardio-Respiratory
ECM - Emergency Care
3.28%
2.53%
2.41%
Corp - Corporate Services
Corp - NHIS
Corp - Human Resources
3.72%
2.73%
1.85%
Progress
Top 3 Staff Groups In Month
Progress
2.51%
Unregistered
Nursing
£22,345
Scientific &
Professional
2.45%
£18,578
1.88%
Admin & Clerical
£36,633
Divisions
In Month
2.15%
1.71%
DRD
£50,466
1.87%
Corporate
£20,224
1.61%
£159,064
ECM
£47,539
1.38%
PCS
£40,839
Progress
Top 3 SMT's
In Month
DRD - New ark
3.99%
DRD - Therapy Services
2.06%
DRD - Support Services
1.85%
Corp-Information Services
Corp - Nursing Services
Corp - Finance
7.08%
5.78%
5.03%
ECM - Support Services
ECM - Gastro Endocrine
ECM - Community Services
2.36%
2.27%
1.64%
PCS - Trauma & Orthopaedics
PCS - Maternity & Gynaecology
PCS - Paediatrics & Neonatal
2.29%
1.62%
1.51%
Progress
Dashboard 2 - Appraisal Sum m ary - Septem ber 13
188
149
667
517
-150
-22.49%
146
113
98
81
321
270
-51
-15.89%
104
985
94
967
108
1127
76
1106
344
3650
300
3657
-44
-12.79%
87.02% 88.86% 73.74% 80.04%
55.96% 65.18% 71.93% 77.67% 70.11% 76.56%
80.62% 80.99% 67.03% 73.68%
50.05% 58.84% 65.04% 72.33% 63.51% 70.28%
Corporate
80.99%
DRD
73.68%
ECM
58.84%
PCS
72.33%
SMT
Aug-13
Cardio-Respiratory 39.41%
Community Services 83.67%
Emergency Care
57.14%
Gastro Endocrine 49.64%
HCOP
66.03%
Non Acute Medicine 57.89%
Support Services 34.55%
Sep-13
45.41%
73.27%
68.28%
55.97%
77.48%
57.89%
42.26%
Progress
6.00%
-10.41%
11.14%
6.34%
11.46%
0.00%
7.71%
Req
Im pr.
33.59%
SMT
Anaesthetics
General Surgery
Head & Neck
Maternity & Gynae
Childrens Services
Support Services
T&O
ProgSep-13 ress
41.46% 3.66%
76.16% 9.49%
65.52% 2.61%
67.07% 0.14%
72.93% 9.70%
77.81% 2.89%
78.74% 5.46%
Req
Im pr.
37.54%
2.84%
13.48%
11.93%
6.07%
1.19%
0.26%
10.72%
23.03%
1.52%
21.11%
36.74%
Staff Group
A &C
AHP
Ancillary
Nursing Reg
Sci & Prof
Students
Tech & Other
Nursing Unreg
Staff Group
A &C
AHP
Ancillary
Nursing Reg
Sci & Prof
Students
Tech & Other
Nursing Unreg
Staff Group
A &C
AHP
Ancillary
Nursing Reg
Sci & Prof
Students
Tech & Other
Nursing Unreg
Sep -13
ProgReq
Sep-13 ress
Im pr.
47.59% 1.81% 31.41%
86.18% 6.45% -7.18%
91.04% 14.18%
85.11% 5.94%
71.82% 1.77% 7.18%
81.55% 13.13% -2.55%
Jul-13
Aug-13
45.78%
79.74%
76.87%
79.17%
70.05%
68.42%
-2.08%
12.33%
PCS
Aug -13
SMT
New ark
Pathology
Radiology
Sexual Health
Support Services
Therapy Services
-1.00%
Staff Group
A &C
AHP
Ancillary
Nursing Reg
Sci & Prof
Students
Tech & Other
Nursing Unreg
ECM
Jun-13
Req
Im pr.
30.35%
31.94%
Apr -13
ProgSep-13 ress
48.65% -5.64%
47.06% -12.46%
88.10% 2.05%
84.03% 2.84%
80.00% -2.76%
99.25% 8.27%
81.08% -2.70%
66.67% 2.38%
DRD
May-13
Aug-13
54.29%
59.52%
86.05%
81.20%
82.76%
90.98%
83.78%
64.29%
Central
Jan-13
SMT
Corp Dev
Corp Services
Finance
HR
Info Services
NHIS
Nursing Services
Strategy & Dev
11.08%
-3.40%
-1.20%
12.51%
AFC Divisional Appraisal Rates
85.00%
80.00%
75.00%
70.00%
65.00%
60.00%
55.00%
50.00%
45.00%
40.00%
35.00%
Feb-13
Req
Im pr.
12.86%
-4.57%
Dec-12
ProgSep-13 ress
66.14% 2.37%
83.57% 14.20%
86.79% 1.61%
67.92% 4.72%
82.40% 12.96%
80.20% 5.96%
66.49% 4.37%
Nov-12
Aug-13
63.77%
69.38%
85.19%
63.20%
69.44%
74.25%
62.13%
Oct-12
Staff Group
A &C
AHP
Ancillary
Nursing Reg
Sci & Prof
Tech & Other
Nursing Unreg
Aug-13
37.80%
66.67%
62.90%
66.93%
63.24%
74.92%
73.28%
10.87%
191
Appraisal
Rates
70.28%
252
242
A ppra is a l R a t e s
e xc ne w to po s t
Trust
Progress
ECM
PCS
Grand Total
Aug-13 Sep-13 Aug-13 Sep-13 Aug-13 Sep-13
493
569
733
800
2318
2570
Mar-13
Appraisal
Corporate
DRD
Status
Aug-13 Sep-13 Aug-13 Sep-13
1) Completed
362
375
730
826
2) Outstanding
>12 months old
46
39
191
138
4) No Appraisal
date reported
8
8
69
68
5) Appraisal Not
Due - New to
post
33
41
99
89
Grand Total
449
463
1089
1121
Total
ProgReq
Rate
ress
Im pr.
76.75% -0.71%
2.25%
100.00%
77.78%
0.00%
-2.22%
-21.00%
1.22%
73.33% -13.33%
5.67%
Rate
67.77%
81.73%
80.00%
60.38%
76.47%
74.29%
68.00%
ProgReq
ress
Im pr.
-4.59% 11.23%
12.88%
-2.73%
13.33%
-1.00%
10.07% 18.62%
8.05%
2.53%
7.81%
1.67%
4.71%
11.00%
ProgReq
Rate
ress
Im pr.
42.37% 6.66% 36.63%
83.33% 50.00%
-4.33%
68.75% 0.00% 10.25%
54.26% 5.83% 24.74%
82.35% 35.29%
-3.35%
71.83%
59.53%
2.82%
8.56%
7.17%
19.47%
ProgReq
Rate
ress
Im pr.
40.00% 0.70% 39.00%
75.00% 0.00%
4.00%
92.86% 3.57% -13.86%
73.10% 3.29%
5.90%
87.30% 18.55%
-8.30%
0.00% 0.00% 79.00%
106.25% 11.66% -27.25%
68.89% 1.00% 10.11%